While artificial intelligence can accelerate scientific discovery, moving discoveries toward practical applications stilldepends onhuman collaboration. That idea shaped 91Ʋ’s 2026 Life Science Showcase: AI in Translational 91Ʋ.
Organized by theteam within the, the showcase has grown from about 60 attendees at its first event four years ago tomore than280registrantsthis year.Attendees from 91Ʋ,91Ʋ University Medical Center, industry, government, venturecapitaland nonprofit organizations gathered to explore how AI can help move research toward real-world use.
The showcase is designed to “pull back the curtain” on life sciences researchacross 91ƲandVUMC andintroduce that work topartnerswhocan help move discoveries toward application, said Chris Rowe,executive director for industry collaborations.
Susan Margulies, vice provost for research and innovation, formally opened the event by emphasizing that translational research relies on strong ties between researchers, clinicians, engineers,investorsand communities.
Margulies emphasized AI’s potential to help researchers integrate large datasets,identifynewinsightsand accelerate discoverieswellbeyond what individual investigators or teamscanaccomplishalone.
“We need to convert that computational breakthrough to real-world therapies and impacts,” she said. She pointed to 91Ʋ’s investments in computational infrastructure, interdisciplinaryresearchandcross-sector partnerships as essential to advancing translational research in the age of AI.
Presentations from 91Ʋ and VUMC researchers,along withleaders from the pharmaceutical and technology industries, gaveattendees a view of how AI is being used across academic research, drugdiscoveryand commercial development.
A cross-disciplinary panel “Will AI Replace Experimental Science?” examined both the potential andthelimitations of using AI in research.Panelists described how AI can accelerate data analysis, molecular design, targetidentificationand hypothesis generation while also sharing examples of computational findings that initially appeared meaningful but wereultimately tracedto misleading clinical records, experimentalartifactsor poorly structured data.
AI systemsremaindependent on the quality and context of the information they receive,according to the panel,underscoring the need for researchers to examine and experimentallyvalidateAI-generated predictions.
Bennett Landman, director of the,urged attendeesin his closing commentsto look beyond individual technologies and molecular discoveries and consider how those advancesultimately cometogether to improve lives.
“It is clear how AI can accelerate research and translate discoveries into meaningful outcomes,” Rowe said. “The power of events like the Life Science Showcase and the role of universities broadly are to convene people, enable partnerships and drive sustainable collaborations.”